Filing Details
- Accession Number:
- 0001209191-17-013805
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-23 16:37:57
- Reporting Period:
- 2017-02-22
- Filing Date:
- 2017-02-23
- Accepted Time:
- 2017-02-23 16:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000228 | Henry Schein Inc | HSIC | Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) | 113136595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194353 | Steven Paladino | C/O Henry Schein, Inc. 135 Duryea Road Melville NY 11747 | Evp, Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Disposition | 2017-02-22 | 10,472 | $173.26 | 76,433 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2017-02-22 | 2,600 | $173.95 | 73,833 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | 3,336 | Indirect | by 401(k) plan |
Footnotes
- The price reflects a weighted average of sales made at prices ranging from $172.790 to $173.745 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.
- The price reflects a weighted average of sales made at prices ranging from $173.800 to $174.140 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.
Billionaire Hedge Funds
